ATXN3 and Spinocerebellar ataxia type 3: Identifying additional substrates of ataxin-3's DUB function and profiling how their interaction with ataxin-3 is impacted by polyQ expansion in ataxin-3 would be valuable for the development of novel targets for therapeutic treatment of MJD and other complex diseases [137].